Loading clinical trials...
Loading clinical trials...
Prospective Study With HIPEC-AS in Patients With Locally Advanced, Limited or Extensive Peritoneal Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
Conditions
Interventions
HIPEC
Paclitaxel-albumin
+2 more
Start Date
October 1, 2021
Primary Completion Date
October 1, 2023
Completion Date
October 1, 2026
Last Updated
October 27, 2021
NCT06519591
NCT06885697
NCT06630130
NCT07035587
NCT05722275
NCT03834272
Lead Sponsor
Xuefei.Wang
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions